XML 45 R34.htm IDEA: XBRL DOCUMENT v3.20.2
Stock-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2020
Share-based Payment Arrangement [Abstract]  
Schedule of Estimated Values of Stock Option Grants Valuation Assumptions

The weighted average estimated values of director and employee stock option grants, as well as the weighted average assumptions that were used in calculating such values during the nine months ended September 30, 2020 and 2019, were based on estimates at the date of grant as follows:

 

    April 30,     January 1,     February 10,  
    2015 Grant     2016 Grant     2016 Grant  
Risk-free interest rate     1.43 %     1.76 %     1.15 %
Weighted average expected term     5 years       5 years       5 years  
Expected volatility     143.10 %     134.18 %     132.97 %
Expected dividend yield     0.00 %     0.00 %     0.00 %

 

    December 6,     September 25,     January 30,  
    2016 Grant     2017 Grant     2019 Grant  
Risk-free interest rate     1.84 %     1.85 %     2.54 %
Weighted average expected term     5 years       5 years       5 years  
Expected volatility     123.82 %     130.79 %     115.80 %
Expected dividend yield     0.00 %     0.00 %     0.00 %

 

    March 11,     September 2,  
    2019 Grant     2020 Grant  
Risk-free interest rate     2.44 %     0.26 %
Weighted average expected term     5 years       5 years  
Expected volatility     116.46 %     121.33 %
Expected dividend yield     0.00 %     0.00 %
Schedule of Stock Option Activity

A summary of stock option activity during the nine months ended September 30, 2020 and 2019 is as follows:

 

                Weighted-      
          Weighted-     Average      
    Shares     Average     Remaining   Aggregate  
    Under     Exercise     Contractual   Intrinsic  
    Option     Price     Life   Value  
Outstanding at January 1, 2020     46,860     $ 9.02     9 years     19,200  
Granted     99,000       4.00              
Outstanding at September 30, 2020     145,860     $ 5.61     9 years   $ 19,200  
                             
Exercisable at September 30, 2020     38,785     $ 9.54     8 years   $ 19,200  

 

                Weighted-      
          Weighted-     Average      
    Shares     Average     Remaining   Aggregate  
    Under     Exercise     Contractual   Intrinsic  
    Option     Price     Life   Value  
Outstanding at January 1, 2019     36,760     $ 25.04     8 years     79,200  
Granted     43,550       6.72              
Forfeited and expired     (33,450 )     43.00              
                             
Outstanding at September 30, 2019     46,860     $ 9.02     9 years   $ 19,200  
                             
Exercisable at September 30, 2019     34,960     $ 9.87     9 years   $ 19,200